Categories
Archives
Other Sites
- tummy tuck cost
- tummy tuck surgery
- breast enhancement
- saline breast implants
- Affordable medical tourism
- Boob job cost
- lower blepharoplasty
- What is medical tourism
- medical tourism companies
- breast augmentation surgery
- Calf implants
- Breast lift and augmentation
- abdominoplasty surgery cost
- breast enlargement surgery
- How much do breast implants cost
- body contouring surgery
- breast implant cost
- celebrity plastic surgery
- how much are breast implants
- The Truth about Silicone Breast Implants
Category Archives: Cell Medicine
Biocept to Present at the Molecular Medicine Tri-Conference on Circulating Tumor Cell (CTC) Technologies
SAN DIEGO–(BUSINESS WIRE)– Biocept, Inc., a privately-held, CLIA certified laboratory testing company focused on detection and analysis of circulating tumor cells (CTCs) in cancer patients, announced that two of its senior scientists, Farideh Bischoff, Ph.D., Vice President of Translational Research, and Lyle Arnold, Ph.D., Senior Vice President, R&D and Chief Scientific Officer, will be making presentations at the 19th Annual Molecular Medicine Tri-Con being held in San Francisco February 19-23. Dr. Continue reading
Posted in Cell Medicine
Tagged a-blood-sample-, analysis, california, capture, development, healthcare, identification, medicine, medicine-tri-, oncoceetm, president, san, tumor-cells
Comments Off
Research and Markets: Evolutionary Biology: Cell-Cell Communication, and Complex Disease – An Integrative View of the …
Please check the URL for proper spelling and capitalization. If you're having trouble locating a destination on Yahoo!, try visiting the Yahoo! homepage or look through a list of Yahoo!'s online services. Continue reading
Posted in Cell Medicine
Tagged central, estination-on-yahoo, having-trouble, look-through, spelling-and, try-visiting, url, yahoo, you-need
Comments Off
A breakthrough in understanding the biology and treatment of ovarian cancer
Public release date: 21-Feb-2012 [ | E-mail | Share ] Contact: Dr. Continue reading
Posted in Cell Medicine
Tagged course, experimental, february, inhibitory, ogf, professor, receptor, society, study, university, usa
Comments Off
Novo Energies Corporation Announces Dr. Michael Har-Noy's Seminar to The Johns Hopkins Institute for Cell Engineering
NEW YORK, NY–(Marketwire -02/21/12)- Novo Energies Corporation (“Novo”) (OTC.BB: NVNC.OB – News) today announced that Dr. Michael Har-Noy, Founder and Chief Executive Officer of Immunovative Therapies, Ltd. (“Immunovative”), was invited to present Immunovative's technologies to The Johns Hopkins Institute for Cell Engineering on February 14, 2012. Continue reading
Posted in Cell Medicine
Tagged a-and-intends, ability, chief, chief-executive, development, existing, immunovative, johns-hopkins, medicine, misgav-venture, office, power, securities, university, york
Comments Off
Renato Dulbecco, 1975 Nobel medicine prize winner, dies at 97
ROME – Renato Dulbecco, who shared the 1975 Nobel Prize in medicine for his seminal research on the interaction between tumors and cells, has died in California. He was 97 Continue reading
Posted in Cell Medicine
Tagged council, genetic, human, human-genome, interaction, italy, russian, science
Comments Off
Renato Dulbecco dies at 97; 1975 Nobel Prize winner in medicine
Dr. Renato Dulbecco, an Italian American virologist who shared the 1975 Nobel Prize in physiology or medicine for demonstrating how certain types of viruses invade mammalian cells to cause cancer, died of natural causes Sunday at his home in La Jolla Continue reading
Italian Nobel medicine winner Dulbecco dies at 97
ROME (AP) — Renato Dulbecco, who shared the 1975 Nobel Prize in medicine for his seminal research on the interaction between tumors and cells, has died in California. He was 97. Dulbecco, an early proponent of sequencing genomes that led to the Human Genome Project, died in La Jolla, California overnight, Italy's National Research Council — where Dulbecco worked on the genome project in the 1990s — said Monday. Continue reading
Posted in Cell Medicine
Tagged california, england, genetic, interaction, italy, london, nobel, rome, russian
Comments Off
BioTime CEO Michael D. West to Present at New York Stem Cell Summit
ALAMEDA, Calif.–(BUSINESS WIRE)– BioTime, Inc. (NYSE Amex: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that Chief Executive Officer Michael D. Continue reading
Posted in Cell Medicine
Tagged a-high-unmet, a-treatment-and, a-wide-array, applications, business, california, chief-executive, development, developmental, diagnostic-, field, manufacturing, officer-michael, results, statements
Comments Off
On-Q-ity to Present at the Molecular Medicine Tri-Conference
WALTHAM, Mass., Feb. 17, 2012 (GLOBE NEWSWIRE) — On-Q-ity, a life sciences company focused on novel circulating tumor cell (CTC) capture and characterization for clinical researchers and physicians that will enhance decision-making across multiple cancer types, today announced that it will be a corporate sponsor of the Molecular Medicine Tri-Conference being held in San Francisco February 21-23 and will be presenting during the Circulating Tumor Cells Conference Program Continue reading
Posted in Cell Medicine
Tagged a-life-sciences, across-multiple, chronic-disease, circulating, diego-february, director, life-sciences, molecular, survival-rates-, talk-on-tuesday, tumor-cells
Comments Off
Histogenics to Present at 7th Annual New York Stem Cell Summit
WALTHAM, Mass.–(BUSINESS WIRE)– Histogenics Corporation, a privately held regenerative medicine company, today announced that the Company will present at the 7th Annual New York Stem Cell Summit on February 21st at Bridgewaters New York City. Kirk Andriano, Ph.D., Vice President of Research and Development for Histogenics, will speak about current and future cell therapies being developed by the Company as it works toward commercialization. Lead candidates include NeoCart®, an autologous bioengineered neocartilage grown outside the body using the patient’s own cells for the regeneration of cartilage lesions, and VeriCart™, a three-dimensional cartilage matrix designed to stimulate cartilage repair in a simple, one-step procedure. Continue reading
Posted in Cell Medicine
Tagged after-reporting, and-immobility-, being-developed, clinical-trials, development, phase, president, university, work
Comments Off